JESSICA PACK: Open Payments
NPI 1982319067 · BASTROP, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 63 payments from 12 companies in 2025. Trend: 2023 $544 · 2024 $731 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 16 | $379 |
| ABBVIE INC. | 13 | $193 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $154 |
| QOL Medical, LLC | 6 | $146 |
| Aimmune Therapeutics, Inc. | 5 | $93 |
| Janssen Biotech, Inc. | 4 | $75 |
| Phathom Pharmaceuticals, Inc. | 4 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Gilead Sciences, Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
Products named: IBSRELA, Sucraid, XIFAXAN, SKYRIZI, TREMFYA, RELISTOR, RINVOQ, VOWST.
Industry payments across LA — which companies pay providers there.
